世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

アジア太平洋地域のラットモデル市場予測 2019-2027年

ASIA PACIFIC RAT MODEL MARKET FORECAST 2019-2027

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2019年1月US$1,250
シングルユーザライセンス(印刷不可PDF)
77

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートはアジア太平洋地域のラットモデル市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
The Asia-Pacific rat model market is anticipated to grow at a CAGR of 9.13 % for the forecast period of 2019-2027 and is expected to generate a revenue of $XX thousand by the year 2027. The rising demand for research activities in the Asia-Pacific countries has increased the opportunities for this market by many folds.

MARKET INSIGHTS

The Asia-Pacific market is rapidly flourishing because of major drivers like supportive R&D incentive schemes for Contract Research Organizations, biotechnological complies and the booming pharmaceutical sectors in regional countries such as Australia, India and China. Presently, India has the third largest pharmaceutical industry in the world whereas, China is presently the second largest investor in research & development globally, and is expected to overtake US research & development investments by the year 2023. The toxicology application is dominating the current market scene. However, the oncology market is fast growing owing to the increasing number of cancer cases worldwide and is estimated to grow at a CAGR of xx % by 2027. On the basis of the market segmentation by type, the genetically engineered outbred type is seemingly a fast emerging market growing at a CAGR of xx% whereas the other types such as surgically modified rats, inbred, hybrid and immune-deficient rats are expected to grow at a CAGR of xx%, xx%, xx% and xx% respectively over the forecast period. By the market segmentation by component, the services sector is predicted to lead the market and is predicted to grow faster at a CAGR of xx% by the end of the forecast period.

COMPETITIVE INSIGHTS

The leading companies players in the Asia-Pacific Rat Model market are Taconic Biosciences, Transviragen Inc., Transposagen Biopharmaceuticals Inc., Charles River Laboratories Inc., Laboratory Corporation of America Holdings, Vivo Biotech Ltd., Cyagen Biosciences Inc., Genoway S.A., Sage Labs Inc. (Acquired By Horizon Discovery Group PLC), Hera Biolabs Inc., Envigo, Biomere, Clea Japan, Janvier Labs and Oncodesign S.A.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. OUTBRED RAT TYPE HOLDS THE MAJOR SHARE IN THE RAT MODEL MARKET
3.2.2. ONCOLOGY IS THE FASTEST GROWING APPLICATION
3.2.3. RAT CARE PRODUCTS ARE SIGNIFICANTLY GROWING
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. ENHANCEMENT IN GENOME EDITING
4.2.2. GROWING AVAILABILITY IN TRANSGENIC RAT
4.2.3. SWELLING PHARMACEUTICAL AND BIOTECHNOLOGY CORPORATIONS R&D
4.3. MARKET RESTRAINTS
4.3.1. PRACTICE OF ANIMALS IN RESEARCH IS CONSIDERED UNETHICAL
4.3.2. USE OF ZEBRAFISH IN RESEARCH IS THE GROWING MODEL
4.3.3. IN VITRO AND ALTERNATIVE TESTING TECHNIQUES MODELS FOR RESEARCH
4.4. MARKET OPPORTUNITIES
4.4.1. PERSONALIZED MEDICINE ESTABLISHED TO SURGE DEMAND
4.4.2. ESCALATION IN MONOCLONAL ANTIBODY CREATION
4.5. MARKET CHALLENGES
4.5.1. HIGHLY EXPENSIVE RAT MODEL
5. MARKET BY RAT TYPE
5.1. INBRED
5.2. GENETICALLY ENGINEERED RATS
5.3. SURGICALLY MODIFIED RATS
5.4. HYBRID
5.5. OUTBRED
5.6. IMMUNE-DEFICIENT
6. MARKET BY APPLICATION
6.1. DIABETES
6.2. TOXICOLOGY
6.3. ONCOLOGY
6.4. IMMUNOLOGY & INFLAMMATION
6.5. OTHER APPLICATION
7. MARKET BY COMPONENT
7.1. TECHNOLOGY
7.1.1. NUCLEAR TRANSFERASE
7.1.2. MICROINJECTION
7.1.3. EMBRYONIC STEM CELL INJECTION
7.1.4. OTHER TECHNOLOGY
7.2. SERVICES
7.3. RAT CARE PRODUCTS
7.3.1. FEED
7.3.2. BEDDING
7.3.3. CAGES
7.3.4. OTHER RAT CARE PRODUCTS
8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCE MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE PRODUCT
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER OF SUPPLIERS
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. VALUE CHAIN ANALYSIS
8.3. REGULATORY FRAMEWORK
8.4. KEY BUYING CRITERIA
8.4.1. HIGH ACCURACY
8.4.2. HIGH EFFICACY
8.4.3. QUALITY OF OPERATING PROCEDURE
8.4.4. PRICE
8.5. OPPORTUNITY MATRIX
9. GEOGRAPHICAL ANALYSIS
9.1. ASIA PACIFIC
9.1.1. INDIA
9.1.2. CHINA
9.1.3. JAPAN
9.1.4. SOUTH KOREA
9.1.5. AUSTRALIA
9.1.6. REST OF ASIA PACIFIC
10. COMPETITIVE LANDSCAPE
10.1. MARKET POSITION ANALYSIS
10.2. COMPANY PROFILES
10.2.1. BIOMERE
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCT PORTFOLIO
10.2.1.3. SCOT ANALYSIS
10.2.2. CHARLES RIVER LABORATORIES INC.
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCT PORTFOLIO
10.2.2.3. SCOT ANALYSIS
10.2.2.4. STRATEGIC INITIATIVES
10.2.3. CLEA JAPAN
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. PRODUCT PORTFOLIO
10.2.3.3. SCOT ANALYSIS
10.2.3.4. STRATEGIC INITIATIVES
10.2.4. CYAGEN BIOSCIENCES INC.
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. PRODUCT PORTFOLIO
10.2.4.3. SCOT ANALYSIS
10.2.5. ENVIGO
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCT PORTFOLIO
10.2.5.3. STRATEGIC INITIATIVES
10.2.6. GENOWAY S. A.
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. PRODUCT PORTFOLIO
10.2.6.3. SCOT ANALYSIS
10.2.6.4. STRATEGIC INITIATIVES
10.2.7. HERA BIOLABS INC.
10.2.7.1. COMPANY OVERVIEW
10.2.7.2. PRODUCT PORTFOLIO
10.2.7.3. SCOT ANALYSIS
10.2.7.4. STRATEGIC INITIATIVE
10.2.8. JANVIER LABS
10.2.8.1. COMPANY OVERVIEW
10.2.8.2. PRODUCT PORTFOLIO
10.2.8.3. SCOT ANALYSIS
10.2.9. LABORATORY CORPORATION OF AMERICA HOLDINGS
10.2.9.1. COMPANY OVERVIEW
10.2.9.2. PRODUCT PORTFOLIO
10.2.9.3. STRATEGIC INITIATIVES
10.2.10. ONCODESIGN S.A.
10.2.10.1. COMPANY OVERVIEW
10.2.10.2. PRODUCT PORTFOLIO
10.2.10.3. SCOT ANALYSIS
10.2.10.4. STRATEGIC INITIATIVE
10.2.11. SAGE LABS INC. (ACQUIRED BY HORIZON DISCOVERY GROUP PLC.)
10.2.11.1. COMPANY OVERVIEW
10.2.11.2. PRODUCT PORTFOLIO
10.2.11.3. SCOT ANALYSIS
10.2.11.4. STRATEGIC INITIATIVES
10.2.12. TACONIC BIOSCIENCES
10.2.12.1. COMPANY OVERVIEW
10.2.12.2. PRODUCT PORTFOLIO
10.2.12.3. SCOT ANALYSIS
10.2.12.4. STRATEGIC INITIATIVES
10.2.13. TRANSPOSAGEN BIOPHARMACEUTICALS INC
10.2.13.1. COMPANY OVERVIEW
10.2.13.2. PRODUCT PORTFOLIO
10.2.13.3. SCOT ANALYSIS
10.2.13.4. STRATEGIC INITIATIVES
10.2.14. TRANSVIRAGEN INC.
10.2.14.1. COMPANY OVERVIEW
10.2.14.2. PRODUCT PORTFOLIO
10.2.14.3. SCOT ANALYSIS
10.2.15. VIVO BIOTECH LTD.
10.2.15.1. COMPANY OVERVIEW
10.2.15.2. PRODUCT PORTFOLIO
10.2.15.3. SCOT ANALYSIS
10.2.15.4. STRATEGIC INITIATIVES

LIST OF TABLES
TABLE 1 ASIA PACIFIC RAT MODEL MARKET 2019-2027 ($ MILLION)
TABLE 2 BENEFITS OF TRANSGENIC RAT
TABLE 3 ASIA PACIFIC RAT MODEL MARKET BY RAT TYPE 2019-2027 ($ MILLION)
TABLE 4 EXAMPLES OF INBRED RATS AND RESEARCH APPLICATIONS
TABLE 5 ASIA PACIFIC INBRED MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC GENETICALLY ENGINEERED RATS MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC SURGICALLY MODIFIED RATS MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC HYBRID MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC OUTBRED MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC IMMUNE-DEFICIENT MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC RAT MODEL MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC DIABETES MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC TOXICOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC ONCOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC IMMUNOLOGY & INFLAMMATION MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC RAT MODEL MARKET BY COMPONENT 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC NUCLEAR TRANSFERASE MARKET 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC MICRO INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 21 ASIA PACIFIC EMBRYONIC STEM CELL INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 22 ASIA PACIFIC OTHER TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 23 ASIA PACIFIC SERVICES MARKET 2019-2027 ($ MILLION)
TABLE 24 ASIA PACIFIC RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 25 ASIA PACIFIC FEED MARKET 2019-2027 ($ MILLION)
TABLE 26 POPULAR FOOD FOR RATS
TABLE 27 ASIA PACIFIC BEDDING MARKET 2019-2027 ($ MILLION)
TABLE 28 ASIA PACIFIC CAGES MARKET 2019-2027 ($ MILLION)
TABLE 29 ASIA PACIFIC OTHER RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 30 ASIA PACIFIC RAT MODEL MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 31 RAT MODEL COMPANY POSITION ANALYSIS

LIST OF FIGURES
FIGURE 1 ASIA PACIFIC RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC RAT MODEL MARKET SHARE BY RAT TYPE 2018 & 2027 (%)
FIGURE 3 ASIA PACIFIC RAT MODEL MARKET BY INBRED 2019-2027 ($ MILLION)
FIGURE 4 ASIA PACIFIC RAT MODEL MARKET BY GENETICALLY ENGINEERED RATS 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC RAT MODEL MARKET BY SURGICALLY MODIFIED RATS 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC RAT MODEL MARKET BY HYBRID 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC RAT MODEL MARKET BY OUTBRED 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC RAT MODEL MARKET BY IMMUNE-DEFICIENT 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC RAT MODEL MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 10 PERCENTAGE OF DIABETES IN WORLD ADULT POPULATION IN 1980, 2015 AND 2040
FIGURE 11 ASIA PACIFIC RAT MODEL MARKET BY DIABETES 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC RAT MODEL MARKET BY TOXICOLOGY 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC RAT MODEL MARKET BY ONCOLOGY 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC RAT MODEL MARKET BY IMMUNOLOGY & INFLAMMATION 2019-2027 ($ MILLION)
FIGURE 15 ASIA PACIFIC RAT MODEL MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC RAT MODEL MARKET SHARE BY COMPONENT 2018 & 2027 (%)
FIGURE 17 ASIA PACIFIC RAT MODEL MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 18 ASIA PACIFIC RAT MODEL MARKET BY NUCLEAR TRANSFERASE 2019-2027 ($ MILLION)
FIGURE 19 ASIA PACIFIC RAT MODEL MARKET BY MICRO INJECTION 2019-2027 ($ MILLION)
FIGURE 20 ASIA PACIFIC RAT MODEL MARKET BY EMBRYONIC STEM CELL INJECTION 2019-2027 ($ MILLION)
FIGURE 21 ASIA PACIFIC RAT MODEL MARKET BY OTHER TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 22 ASIA PACIFIC RAT MODEL MARKET BY SERVICES 2019-2027 ($ MILLION)
FIGURE 23 ASIA PACIFIC RAT MODEL MARKET BY RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 24 ASIA PACIFIC RAT MODEL MARKET BY FEED 2019-2027 ($ MILLION)
FIGURE 25 ASIA PACIFIC RAT MODEL MARKET BY BEDDING 2019-2027 ($ MILLION)
FIGURE 26 ASIA PACIFIC RAT MODEL MARKET BY CAGES 2019-2027 ($ MILLION)
FIGURE 27 ASIA PACIFIC RAT MODEL MARKET BY OTHER RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 28 PORTER’S FIVE FORCE MODEL
FIGURE 29 INDIA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 30 CHINA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 31 CHINESE PHARMACEUTICAL MARKET 2015 & 2020 ($ BILLION)
FIGURE 32 JAPAN RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 33 SOUTH KOREA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 34 AUSTRALIA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 35 REST OF ASIA PACIFIC RAT MODEL MARKET 2019-2027 ($ MILLION)

List of Tables

LIST OF TABLES
TABLE 1 ASIA PACIFIC RAT MODEL MARKET 2019-2027 ($ MILLION)
TABLE 2 BENEFITS OF TRANSGENIC RAT
TABLE 3 ASIA PACIFIC RAT MODEL MARKET BY RAT TYPE 2019-2027 ($ MILLION)
TABLE 4 EXAMPLES OF INBRED RATS AND RESEARCH APPLICATIONS
TABLE 5 ASIA PACIFIC INBRED MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC GENETICALLY ENGINEERED RATS MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC SURGICALLY MODIFIED RATS MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC HYBRID MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC OUTBRED MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC IMMUNE-DEFICIENT MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC RAT MODEL MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC DIABETES MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC TOXICOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC ONCOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC IMMUNOLOGY & INFLAMMATION MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC RAT MODEL MARKET BY COMPONENT 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC NUCLEAR TRANSFERASE MARKET 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC MICRO INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 21 ASIA PACIFIC EMBRYONIC STEM CELL INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 22 ASIA PACIFIC OTHER TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 23 ASIA PACIFIC SERVICES MARKET 2019-2027 ($ MILLION)
TABLE 24 ASIA PACIFIC RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 25 ASIA PACIFIC FEED MARKET 2019-2027 ($ MILLION)
TABLE 26 POPULAR FOOD FOR RATS
TABLE 27 ASIA PACIFIC BEDDING MARKET 2019-2027 ($ MILLION)
TABLE 28 ASIA PACIFIC CAGES MARKET 2019-2027 ($ MILLION)
TABLE 29 ASIA PACIFIC OTHER RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 30 ASIA PACIFIC RAT MODEL MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 31 RAT MODEL COMPANY POSITION ANALYSIS

List of Figures

LIST OF FIGURES
FIGURE 1 ASIA PACIFIC RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC RAT MODEL MARKET SHARE BY RAT TYPE 2018 & 2027 (%)
FIGURE 3 ASIA PACIFIC RAT MODEL MARKET BY INBRED 2019-2027 ($ MILLION)
FIGURE 4 ASIA PACIFIC RAT MODEL MARKET BY GENETICALLY ENGINEERED RATS 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC RAT MODEL MARKET BY SURGICALLY MODIFIED RATS 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC RAT MODEL MARKET BY HYBRID 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC RAT MODEL MARKET BY OUTBRED 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC RAT MODEL MARKET BY IMMUNE-DEFICIENT 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC RAT MODEL MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 10 PERCENTAGE OF DIABETES IN WORLD ADULT POPULATION IN 1980, 2015 AND 2040
FIGURE 11 ASIA PACIFIC RAT MODEL MARKET BY DIABETES 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC RAT MODEL MARKET BY TOXICOLOGY 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC RAT MODEL MARKET BY ONCOLOGY 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC RAT MODEL MARKET BY IMMUNOLOGY & INFLAMMATION 2019-2027 ($ MILLION)
FIGURE 15 ASIA PACIFIC RAT MODEL MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC RAT MODEL MARKET SHARE BY COMPONENT 2018 & 2027 (%)
FIGURE 17 ASIA PACIFIC RAT MODEL MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 18 ASIA PACIFIC RAT MODEL MARKET BY NUCLEAR TRANSFERASE 2019-2027 ($ MILLION)
FIGURE 19 ASIA PACIFIC RAT MODEL MARKET BY MICRO INJECTION 2019-2027 ($ MILLION)
FIGURE 20 ASIA PACIFIC RAT MODEL MARKET BY EMBRYONIC STEM CELL INJECTION 2019-2027 ($ MILLION)
FIGURE 21 ASIA PACIFIC RAT MODEL MARKET BY OTHER TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 22 ASIA PACIFIC RAT MODEL MARKET BY SERVICES 2019-2027 ($ MILLION)
FIGURE 23 ASIA PACIFIC RAT MODEL MARKET BY RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 24 ASIA PACIFIC RAT MODEL MARKET BY FEED 2019-2027 ($ MILLION)
FIGURE 25 ASIA PACIFIC RAT MODEL MARKET BY BEDDING 2019-2027 ($ MILLION)
FIGURE 26 ASIA PACIFIC RAT MODEL MARKET BY CAGES 2019-2027 ($ MILLION)
FIGURE 27 ASIA PACIFIC RAT MODEL MARKET BY OTHER RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 28 PORTER’S FIVE FORCE MODEL
FIGURE 29 INDIA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 30 CHINA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 31 CHINESE PHARMACEUTICAL MARKET 2015 & 2020 ($ BILLION)
FIGURE 32 JAPAN RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 33 SOUTH KOREA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 34 AUSTRALIA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 35 REST OF ASIA PACIFIC RAT MODEL MARKET 2019-2027 ($ MILLION)

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る